Kvacskay, P., & Merkt, W. (2024). CD19.CAR T cells versus obinutuzumab - who will win the race for use in deep B cell depletion therapy in systemic autoimmunity? Rheumatology, 63(9), . https://doi.org/10.1093/rheumatology/keae144
Chicago-Zitierstil (17. Ausg.)Kvacskay, Peter, und Wolfgang Merkt. "CD19.CAR T Cells Versus Obinutuzumab - Who Will Win the Race for Use in Deep B Cell Depletion Therapy in Systemic Autoimmunity?" Rheumatology 63, no. 9 (2024). https://doi.org/10.1093/rheumatology/keae144.
MLA-Zitierstil (9. Ausg.)Kvacskay, Peter, und Wolfgang Merkt. "CD19.CAR T Cells Versus Obinutuzumab - Who Will Win the Race for Use in Deep B Cell Depletion Therapy in Systemic Autoimmunity?" Rheumatology, vol. 63, no. 9, 2024, https://doi.org/10.1093/rheumatology/keae144.